Tag results:
epithelial cells
Pulmonary Cell News
Lipidomic Profiling of Bronchoalveolar Lavage Fluid Extracellular Vesicles Indicates Their Involvement in Lipopolysaccharide-Induced Acute Lung Injury
[Journal of innate Immunity] Extracellular vesicles released during acute lung injury originated from alveolar epithelial cells, macrophages, and neutrophils and carry a diverse array of lipid mediators derived from ω-3 and ω-6 polyunsaturated fatty acids.
Pulmonary Cell News
USP28 Enables Oncogenic Transformation of Respiratory Cells and Its Inhibition Potentiates Molecular Therapy Targeting Mutant EGFR, BRAF and PI3K.
[Molecular Oncology] Targeting ubiquitin carboxyl-terminal hydrolase 28 (USP28) protein abundance at an early stage via inhibition of its activity is a feasible strategy for the treatment of early-stage lung tumors.
Pulmonary Cell News
Inhibition of SARS-CoV-2 Replication in the Lung with siRNA/VIPER Polyplexes
[Journal of Controlled Release] Researchers developed a formulation for pulmonary administration of siRNA to suppress SARS-CoV-2 replication in lung epithelial cells.
Pulmonary Cell News
Hedgehog-Responsive PDGFRa(+) Fibroblasts Maintain a Unique Pool of Alveolar Epithelial Progenitor Cells during Alveologenesis
[Cell Reports] Scientists showed that during alveologenesis, Hedgehog-responsive PDGFRa(+) progenitors were a source of secreted trophic molecules that maintained a unique lung alveolar type 2 progenitor population.
Immunology of Infectious Disease News
The Candida albicans Toxin Candidalysin Mediates Distinct Epithelial Inflammatory Responses through p38 and EGFR-ERK Pathways
[Science Signaling] In cultured oral epithelial cells, candidalysin activated the MAPK p38, which resulted in heat shock protein 27 (Hsp27) activation, IL-6 release, and EGFR phosphorylation without affecting the induction of c-Fos.
Cell Therapy News
Poly(I:C) Enhances Mesenchymal Stem Cell Control of Myeloid Cells From COVID-19 Patients
[iScience] The authors hypothesized that viral mimic-priming improved mesnchymal stem cells' abilities to rebalance the dysregulated immune responses in COVID-19.